Tacillizumab Tablet

Tacilizumab is typically administered as an injectable drug; it is not available in tablet form. The biologic pharmaceutical tacilizumab is a member of the group of drugs known as interleukin-6 (IL-6) inhibitors. It is used to treat a number of autoimmune diseases, including giant cell arteritis and rheumatoid arthritis. Tacilizumab reduces inflammation and inhibits the immune system by inhibiting the IL-6 receptor. It aids in symptom relief, enhances joint performance, and slows the spread of disease. The dosage and frequency of tacilizumab administration should be determined by a physician and are based on the condition being treated.